Asymmetric Walking Protocols for ACL Reconstruction
Trial Summary
What is the purpose of this trial?
The purpose of this work is to conduct a comparative research-focused study to evaluate the effectiveness of how purposefully induced asymmetric walking protocols restore healthy, symmetric limb loading in individuals following post-anterior cruciate ligament reconstruction (ACLR) surgery. Additionally, computational modeling and machine learning to model knee loading in the clinic to determine the optimal asymmetric walking protocol to restore healthy gait in post-ACLR individuals.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Asymmetric Walking Protocol for ACL reconstruction?
Is the Asymmetric Walking Protocol safe for humans?
How does the Asymmetric Walking Protocol treatment differ from other treatments for ACL reconstruction?
The Asymmetric Walking Protocol is unique because it focuses on retraining walking patterns to address movement asymmetries after ACL reconstruction, which are common and can lead to further joint issues. Unlike traditional therapies that may emphasize symmetry, this protocol specifically targets and adjusts the asymmetrical gait patterns to improve overall function and prevent long-term complications.13459
Research Team
Kristin Morgan, PhD
Principal Investigator
University of Connecticut
Eligibility Criteria
This trial is for individuals aged 18-30 who have undergone ACL reconstruction at the UConn Musculoskeletal Institute and are cleared to return to sport. They must show a significant difference in limb loading when walking, speak English, and not have other injuries or conditions that affect movement.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants perform two asymmetric walking sessions with between-limb gait speed differences of 0.25 m/s and 0.50 m/s, each on separate days with at least 3 weeks between sessions.
Follow-up
Participants are monitored for changes in knee loading and gait adaptation immediately following the completion of the second session.
Treatment Details
Interventions
- Asymmetric Walking Protocol (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Connecticut
Lead Sponsor
Lisa Dunkle
University of Connecticut
Chief Medical Officer since 2018
MD from Johns Hopkins University
Erika Smith
University of Connecticut
Chief Executive Officer since 2020
MBA from the University of Connecticut
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator
Dr. Lindsey A. Criswell
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Director since 2021
MD, MPH, DSc
Dr. Robert Colbert
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Clinical Director since 2014
MD